Page last updated: 2024-08-24

goralatide and Neoplasms

goralatide has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bignon, J; Garcia-Alvarez, MC; Kusinski, M; Kuzdak, K; Liu, JM; Riches, A; Wdzieczak-Bakala, J	1
Abali, H; Engin, H; Erman, M; Güllü, IH; Haznedaroğlu, IC; Tekuzman, G	1
Carde, P; Frindel, E; Tubiana, M	1
Comte, L; Lorgeot, V; Praloran, V; Roullet, B; Tubiana, N; Volkov, L	1

Reviews

2 review(s) available for goralatide and Neoplasms

Article	Year
Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases. Annals of the New York Academy of Sciences, 2010, Volume: 1194 Topics: Animals; Biochemical Phenomena; Dipeptides; Mice; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Prolyl Oligopeptidases; Serine Endopeptidases; Thymosin	2010
Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs--the possible role of inhibitors. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1993, Volume: 29, Issue:1 Topics: Animals; Antineoplastic Agents; Hematopoiesis; Hematopoietic Stem Cells; Humans; Mice; Neoplasms; Oligopeptides; Radiotherapy	1993

Other Studies

2 other study(ies) available for goralatide and Neoplasms

Article	Year
Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Medical hypotheses, 2002, Volume: 59, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Platelets; Carcinoma, Lewis Lung; Drug Evaluation, Preclinical; Endothelial Growth Factors; Hematopoiesis; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Oligopeptides; Platelet Activation; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens. Cancer letters, 1997, Jan-15, Volume: 112, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorouracil; Growth Inhibitors; Humans; Male; Middle Aged; Neoplasms; Oligopeptides	1997

Article

Year

Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Medical hypotheses, 2002, Volume: 59, Issue:3

Topics: Angiogenesis Inhibitors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Platelets; Carcinoma, Lewis Lung; Drug Evaluation, Preclinical; Endothelial Growth Factors; Hematopoiesis; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Oligopeptides; Platelet Activation; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens.

Cancer letters, 1997, Jan-15, Volume: 112, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorouracil; Growth Inhibitors; Humans; Male; Middle Aged; Neoplasms; Oligopeptides

1997